Key Updates
British American Tobacco has declined -2.24% since the last report to £4,283, with YTD gains now compressed to +1.64% from the previous +3.96%. The stock continues its consolidation pattern below the £4,400-£4,500 resistance zone established in early February. Recent developments include positive momentum on the regulatory front with potential ITC action against illegal vapes, though the South African factory closure signals operational rationalization amid illicit trade pressures. The ongoing North Korea terrorism lawsuit represents a significant legal overhang, though the financial impact remains uncertain given the 2023 settlement already paid.
Current Trend
BAT remains in a modest uptrend with YTD gains of +1.64%, though momentum has weakened considerably from the +6.41% peak reached on February 12. The stock has declined -3.88% over the past five days and -2.24% since the last report, establishing a clear resistance zone at £4,400-£4,500. Short-term price action suggests consolidation, with the stock trading approximately -5% below its recent February highs. Support appears to be forming around the £4,280-£4,300 level, with the six-month performance of +2.02% indicating limited directional conviction. The one-month decline of -0.99% reflects persistent selling pressure following the February 12 earnings-driven rally.
Investment Thesis
The investment thesis centers on BAT's transformation from a traditional tobacco company to a diversified nicotine products provider, with new categories (vapor, heated products, oral pouches) representing the primary growth driver. The company delivered strong 2025 results with pretax profit surging to £9.86 billion from £3.54 billion, while new categories revenue grew 7% to £3.62 billion. BAT's Velo nicotine pouch brand is gaining U.S. market share against Philip Morris' Zyn, supported by higher nicotine strengths and promotional strategies. However, the thesis faces headwinds from illegal vape competition (70% of U.S. market), declining traditional cigarette volumes, and operational challenges in key markets like South Africa. The company maintains financial discipline with a 2% dividend increase to 245.04 pence per share and operates with strong cash generation capabilities. Regulatory developments, particularly potential ITC import blocks on unauthorized vapes, could materially improve the competitive landscape by 2027.
Thesis Status
The investment thesis remains partially intact but faces near-term execution challenges. The positive elements—strong profit growth, new categories expansion (+7%), and Velo market share gains—support the transformation narrative. However, three significant headwinds have emerged: (1) illegal vape competition undermining both traditional and new category sales, (2) the South African factory closure highlighting the severity of illicit trade impacts (75% of market), and (3) the North Korea terrorism lawsuit creating reputational and potential financial risks beyond the $629 million already paid. The potential ITC action against unauthorized vapes represents a critical catalyst that could validate the thesis, though benefits are unlikely before 2027. The company's ability to maintain market share in new categories while managing traditional business decline remains the key variable, with current evidence suggesting mixed progress.
Key Drivers
Regulatory developments dominate the near-term outlook, with BAT pursuing ITC cases to block unauthorized disposable vape imports, potentially reducing the illegal market by one-third. A full ITC determination is expected in March, followed by a 60-day presidential review, though implementation impact is delayed until 2027 due to supply chain dynamics. Operationally, BAT is closing its South African factory by year-end due to illicit cigarettes comprising 75% of the market, representing an £8 billion loss in annual revenue and costing the government billions in excise taxes. The company faces legal pressure from approximately 200 U.S. victims seeking damages for allegedly enabling North Korea's weapons programs, adding to the $629 million penalty already paid in 2023. Competitively, while Velo gained U.S. market share through higher nicotine strengths and promotions, vape volumes fell 12.8% in 2025 due to illegal product sales. The broader market context includes Philip Morris forecasting strong 2026 growth, though facing similar competitive pressures as Zyn loses market share to rivals including BAT.
Technical Analysis
BAT is trading at £4,283, establishing a consolidation pattern following the failed breakout attempt above £4,500 on February 12. The stock has formed clear resistance at £4,400-£4,500, with three unsuccessful tests in the past week. Immediate support sits at £4,280-£4,300, representing the current price level and the five-day low. A break below this level would target the six-month average around £4,200. The declining momentum indicators—with consecutive negative daily and weekly moves—suggest sellers remain in control near-term. Volume patterns indicate distribution at higher levels, with the -5.49% decline on February 10 representing capitulation selling. The YTD performance of +1.64% places the stock near the lower end of its 2026 trading range, with the six-month gain of +2.02% providing minimal technical cushion. Key levels to monitor: resistance at £4,400 and £4,500, support at £4,280 and £4,200.
Bull Case
- Pretax profit surged 178% to £9.86 billion in 2025, demonstrating exceptional operational leverage and profitability improvement, with adjusted operating profit exceeding consensus at £11.89 billion versus £11.29 billion expected. Source
- ITC action against unauthorized vapes could reduce the illegal U.S. market by one-third, with full determination expected in March 2026 and potential implementation by 2027, addressing the primary headwind affecting both traditional and new category sales. Source
- Velo nicotine pouches are gaining U.S. market share against Philip Morris' Zyn through higher nicotine strengths and promotional strategies, with new categories revenue growing 7% to £3.62 billion and demonstrating successful portfolio transformation. Source
- The company increased its dividend 2% to 245.04 pence per share, maintaining shareholder returns despite operational challenges and demonstrating confidence in cash generation capabilities. Source
- Board extended Chair Luc Jobin's tenure for up to two additional years, signaling continuity in strategic direction and confidence in the transformation program execution. Source
Bear Case
- Approximately 200 U.S. victims filed a terrorism lawsuit seeking unspecified damages beyond the $629 million already paid, creating significant reputational risk and potential for substantial additional financial liability related to North Korea operations. Source
- Illegal vapes comprise approximately 70% of U.S. e-cigarette sales, directly undermining both traditional tobacco and new category businesses, with vape volumes declining 12.8% in 2025 and any regulatory relief unlikely before 2027. Source
- BAT is closing its South African factory by year-end due to illicit cigarettes comprising 75% of the market, representing a complete market failure in a strategic geography and highlighting the company's inability to combat illegal trade despite years of warnings. Source
- Group revenue declined 1% to £25.61 billion in 2025 due to 3.1% foreign exchange headwinds, with traditional cigarette volumes continuing structural decline and no clear path to offsetting losses through new categories at current growth rates. Source
- Philip Morris is forecasting 11.1%-13.1% adjusted EPS growth for 2026 and investing up to $1.6 billion in newer products, intensifying competitive pressure in nicotine pouches and heated tobacco despite Zyn's market share losses. Source